Frontiers in Cardiovascular Medicine

FEBRUARY 27, 2025

BackgroundInstant atrial fibrillation termination (AFT) during radiofrequency ablation has been suggested as a predictor of prognosis in persistent atrial fibrillation (AF). Baseline characteristics, procedural details, and clinical outcomes were compared between the groups.ResultsA total of 189 patients [65.0

Atrial Fibrillation 52

Atrial Fibrillation Ablation Arrhythmia Outcomes 52

Open Heart

JANUARY 21, 2025

Background Atrial fibrillation (AF) and acute myocardial infarction (AMI) share risk factors and are bidirectionally associated. Several studies found higher risks of outcomes in individuals with both conditions. Whether the risks of outcomes differ according to temporal order of AF and AMI is unclear.

Myocardial Infarction 52

Myocardial Infarction Atrial Fibrillation Diet Cancer 52

Medical Xpress - Cardiology

MAY 18, 2024

Atrial fibrillation (AF) is the most common form of arrythmia or irregular heartbeat worldwide, impacting millions of people in the U.S.

Atrial Fibrillation 85

Atrial Fibrillation Best Practices Outcomes Heart Rhythm 85

DAIC

APRIL 18, 2024

Based on continuous monitoring of early recurrence of atrial tachyarrhythmia immediately after patients have undergone atrial fibrillation ablation, Musat et al. recommend shortening the blanking period from three months to one. also emphasize the importance of continuous monitoring.

Atrial Fibrillation 111

Atrial Fibrillation Ablation Heart Rhythm Article 111

Heart BMJ

JANUARY 29, 2025

Background The SCN5A gene polymorphism histidine-558-to-arginine (H558R) has been associated with atrial fibrillation (AF) and may affect the therapeutic effects of flecainide. Secondary analyses evaluated the long-term outcomes and compared the prevalence of H558R in the AF cohort to a general population sample (n=3401).

Atrial Fibrillation 52

Atrial Fibrillation Outcomes 52

Cardiovascular Diabetology

APRIL 4, 2024

This study investigates the relationship between triglyceride-glucose (TyG) index trajectories and the results of ablation in patients with stage 3D atrial fibrillation (AF).

Atrial Fibrillation 105

Atrial Fibrillation Ablation Outcomes Research 105

The New England Journal of Medicine

APRIL 2, 2025

After atrial fibrillation ablation, left atrial appendage closure was associated with a lower risk of bleeding than oral anticoagulation and was noninferior to oral anticoagulation with respect to clinical outcomes at 36 months.

Atrial Fibrillation 74

Atrial Fibrillation Ablation Outcomes 74

DAIC

MAY 18, 2024

During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.

Heart Rhythm 105

Heart Rhythm Atrial Fibrillation Ablation Quality of Life 105

DAIC

DECEMBER 29, 2023

Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF. "The Circulation.

Atrial Fibrillation 115

Atrial Fibrillation Ablation Atrial Flutter Blood Clot 115

Medical Xpress - Cardiology

DECEMBER 18, 2023

Postoperative atrial fibrillation (POAF) is associated with an increased rate of neurologic events and worse long-term survival, according to a study published online Sept. 11 in the Journal of Thoracic and Cardiovascular Surgery.

Atrial Fibrillation 80

Atrial Fibrillation Cardiovascular Surgery Outcomes 80

DAIC

MARCH 28, 2024

Twelve-month outcomes data from the pilot phase of the admIRE study, which assessed the safety and efficacy of the VARIPULSE Platform among U.S. 1 Among 20 patients who completed the 12-month follow-up visit, 100% achieved acute success from ablation procedures and 80% remained free from atrial arrhythmia recurrence at one year.

Atrial Fibrillation 110

Atrial Fibrillation AFIB Ablation Pulmonary 110

HeartRhythm

APRIL 8, 2024

There is insufficient data assessing the regional differences in catheter ablation outcomes for atrial fibrillation (AF) in the United States.

Atrial Fibrillation 75

Atrial Fibrillation Ablation Outcomes Inpatient 75

HeartRhythm

SEPTEMBER 20, 2024

Data on long-term effects of catheter ablation versus antiarrhythmic drugs (AAD) on health-related quality of life (HRQoL) and atrial fibrillation (AF) burden are limited.

Quality of Life 81

Quality of Life Atrial Fibrillation Ablation Outcomes 81

DAIC

JULY 24, 2024

The collaboration, according to a written statement issued by the company, aims to address challenges in capturing and analyzing cardiac signals to help physicians enhance patient outcomes for atrial fibrillation procedures. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

Medical Xpress - Cardiology

JULY 24, 2024

Using a wearable device, such as a smart watch, to track health data and symptoms, is supposed to help people monitor their health and address symptoms as quickly as possible to spur positive health outcomes.

Atrial Fibrillation 75

Atrial Fibrillation AFIB Outcomes 75

Open Heart

MARCH 28, 2025

The primary outcomes of interest were mortality in ventricular and atrial arrhythmias, and later diagnosis of cardiac disease in atrial arrhythmias. The presence of atrial fibrillation (AF) during stress testing was not associated with mortality at all time points: OR 1.53 (95% CI 0.05, 50.19), p=0.81.

Arrhythmia 75

Arrhythmia Coronary Artery Disease Myocardial Infarction Atrial Fibrillation 75

HeartRhythm

MARCH 10, 2025

Ablation index (AI)-guided pulmonary vein isolation (PVI) has enhanced procedural outcomes for atrial fibrillation (AF).1 1 However, patients with persistent AF present higher recurrence rates due to advanced atrial remodeling,2-3 represented by the left atrial low voltage area (LVA), compared to those with paroxysmal AF.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Pulmonary 40

Frontiers in Cardiovascular Medicine

FEBRUARY 5, 2025

This high incidence of cognitive decline in AF patients may result from various mechanisms, including reduced cerebral perfusion, microembolism, decreased cardiac output, and chronic inflammation.MethodsThis review synthesizes current evidence on the relationship between AF and cognitive impairment, examines underlying mechanisms of cognitive decline (..)

Atrial Fibrillation 52

Atrial Fibrillation Ablation Arrhythmia Research 52

Heart BMJ

MARCH 26, 2025

They included randomised controlled trials that enrolled adults undergoing major cardiac surgeries and reported postpericardiotomy syndrome, pericardial effusion and pericarditis as primary or secondary outcomes. Beta-blockers probably prevent atrial fibrillation with a large magnitude of effect (RR 0.4, 95% CI 0.20

Open-Heart Surgery 52

Open-Heart Surgery Pharmacology Atrial Fibrillation Pericarditis 52

American College of Cardiology

FEBRUARY 12, 2025

Additional rhythm-control strategies are frequently continued after index ablation for atrial fibrillation (AFib), according to a study published Feb. 12 in JACC: Clinical Electrophysiology.

Atrial Fibrillation 58

Atrial Fibrillation Ablation AFIB Electrophysiology 58

HeartRhythm

MAY 15, 2024

With the exponential growth of catheter ablation (CA) for atrial fibrillation (AF), there is increasing interest in associated healthcare costs.

Atrial Fibrillation 72

Atrial Fibrillation Ablation Outcomes 72

Journal of Cardiovascular Electrophysiology

APRIL 9, 2025

ABSTRACT Background Sotalol is used for the maintenance of sinus rhythm among patients with atrial fibrillation. To date, use and outcomes by dose are not well-described. However, there is discretion regarding dosing of chronic therapy, and the target oral dose dictates infusion doses for intravenous sotalol loading.

Arrhythmia 40

Arrhythmia Outcomes Atrial Fibrillation Hospital 40

American College of Cardiology

FEBRUARY 23, 2024

What is the prevalence of subclinical atrial fibrillation (AF) in patients with heart failure and preserved ejection fraction (HFpEF), and how does it impact outcomes?

Atrial Fibrillation 66

Atrial Fibrillation Preserved Ejection Fraction Heart Failure Outcomes 66

Frontiers in Cardiovascular Medicine

JANUARY 16, 2024

Introduction Catheter ablation is an effective and safe strategy for treating atrial fibrillation patients. Nevertheless, studies on the long-term outcomes of catheter ablation in patients with dilated cardiomyopathy are limited. Among the catheter ablation group, 58.7% ( n  = 27) had persistent atrial fibrillation.

Atrial Fibrillation 64

Atrial Fibrillation Ablation Cardiomyopathy Heart Failure 64

Cardiovascular Diabetology

MARCH 23, 2025

The triglycerideglucose (TyG) index, an emerging surrogate marker of insulin resistance, has been implicated in adverse cardiovascular outcomes. However, its prognostic value in critically ill patients with a.

Atrial Fibrillation 102

Atrial Fibrillation Outcomes Research 102

Science Daily - Heart Disease

APRIL 22, 2024

Atrial fibrillation is the most common cardiac arrhythmia worldwide with around 59 million people concerned in 2019. Researchers have recently developed a deep-learning model capable of predicting the transition from a normal cardiac rhythm to atrial fibrillation.

Arrhythmia 120

Arrhythmia Atrial Fibrillation Dementia Heart Failure 120

American College of Cardiology

FEBRUARY 19, 2025

Atrial fibrillation catheter ablation (AFCA) improved clinical outcomes compared with medical treatment alone, and early AFCA was associated with better outcomes than late AFCA, particularly decreased risk of heart failure (HF) hospitalization and atrial fibrillation (AFib) recurrence.

AFIB 68

AFIB Ablation Atrial Fibrillation Outcomes 68

HeartRhythm

OCTOBER 23, 2024

Atrial fibrillation (AF) may have different clinical features in its early phase.

Atrial Fibrillation 45

Atrial Fibrillation Outcomes 45

Frontiers in Cardiovascular Medicine

FEBRUARY 7, 2024

Background Efforts to maintain sinus rhythm in patients with persistent atrial fibrillation (PsAF) remain challenging, with suboptimal long-term outcomes. Methods All patients undergoing convergent PsAF ablation at our centre were retrospectively analysed.

Atrial Fibrillation 81

Atrial Fibrillation Ablation Document Obesity 81

Journal of the American Heart Association

DECEMBER 1, 2023

BackgroundAn increased risk of recurrent stroke is noted in patients with atrial fibrillation despite direct oral anticoagulant (DOAC) use. 0.45] for rivaroxaban), and a 69% to 83% reduced risk of net composite outcomes (aHR, 0.25 [95% CI, 0.18–0.35] 0.39] for apixaban, 0.23 [95% CI, 0.14–0.37] 0.41] for rivaroxaban).ConclusionsIn

Atrial Fibrillation 75

Atrial Fibrillation Hemorrhage Pharmacology Strokes 75

CardiacWire

APRIL 5, 2025

Paroxysmal atrial fibrillation is a type of AFib that causes short, intermittent episodes of irregular and rapid heartbeats originating in the atria. Well still have to wait for future studies to see whether PFAs outcomes will match its safety and efficiency benefits. The post PFA or Cryoballoon for Paroxysmal AFib?

AFIB 59

AFIB Ablation Atrial Fibrillation Pulmonary 59

Journal of the American Heart Association

DECEMBER 1, 2023

BackgroundThe incidence and type of complications following catheter ablation of atrial fibrillation have been extensively examined, but the impact associated with these complications on the length of stay and hospitalization costs is unknown.Methods and ResultsThis cohort study included 20 117 adult patients (mean age 62.6±11.4 years,

Atrial Fibrillation 72

Atrial Fibrillation Ablation Hospital Reimbursement 72

Heart BMJ

OCTOBER 10, 2024

The term ‘epidemic’ is increasingly used to describe the rising global prevalence of atrial fibrillation (AF). Indeed, numerous studies are currently investigating the impact of such approaches on clinical outcomes and healthcare utilisation. Recent estimates suggest that AF accounts for between 0.9% 2 Before the.

Atrial Fibrillation 59

Atrial Fibrillation Risk Factors Kidney Disease Heart Failure 59

Journal of the American Heart Association

DECEMBER 14, 2024

BackgroundThe effectiveness of statin use in preventing adverse cardiovascular events in individuals with atrial fibrillation (AF) has remained uncertain. Journal of the American Heart Association, Volume 13, Issue 24 , December 17, 2024.

Atrial Fibrillation 75

Atrial Fibrillation Myocardial Infarction Hemorrhage Heart Failure 75

Frontiers in Cardiovascular Medicine

JULY 31, 2024

Atrial fibrillation (AF) represents the most common cardiac arrhythmia with significant morbidity and mortality implications. This review aims to analyze the existing literature on the effects of dietary modifications on the incidence, progression, and outcomes of atrial fibrillation.

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Diet Arrhythmia 52

Frontiers in Cardiovascular Medicine

MARCH 28, 2025

Initial causality was assessed by inverse variance weighting (IVW), followed by sensitivity analyses using MR-Egger regression, weighted median, and Multiple Effectiveness Residual Sums and Outliers (MR-PRESSO) method.

Cardiovascular Disease 52

Cardiovascular Disease Atrial Fibrillation Aneurysm Heart Failure 52

Circulation

JANUARY 24, 2024

The primary efficacy and safety outcomes were stroke or systemic embolic events (stroke/SEE) and major bleeding, respectively; secondary outcomes were ischemic stroke/SEE, intracranial hemorrhage, death, and the net clinical outcome (stroke/SEE, major bleeding, or death). Each outcome was examined across BMI and BW.

Atrial Fibrillation 80

Atrial Fibrillation BMI Strokes Stroke 80